Skip to main content
Eton Pharmaceuticals, Inc. logo

Eton Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · ETON ISIN · US29772L1089 US Manufacturing
Open in API
Filings indexed 358 across all filing types
Latest filing 2018-11-20 Capital/Financing Update
Country US United States of America
Listing US ETON

About Eton Pharmaceuticals, Inc.

https://etonpharma.com/

Eton Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing treatments for rare diseases. The company's strategy involves sourcing, acquiring, and developing therapies to serve small, underserved patient populations. Eton manages the complete drug development lifecycle, from navigating clinical trials and the regulatory approval process to bringing the final products to market. It actively seeks meaningful therapies from a global network of partners to build a diversified portfolio of treatments.

Recent filings

Filing Released Lang Actions
S-8
Capital/Financing Update Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as equity incentive plans and employee stock purchase plans. It includes detailed information about the securities to be registered, the plans under which they are offered, and related legal and corporate governance information. This type of filing is a capital raising and securities registration document related to employee compensation plans, not a financial report, earnings release, or management discussion. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including registration of securities for employee plans.
2018-11-20 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details amendments to the company's Articles of Incorporation and Bylaws in connection with the closing of the company's IPO. It includes descriptions of the changes to the corporate governance documents and references exhibits containing the full amended documents. There are no financial statements or detailed financial data presented, nor is this an annual or quarterly report. The document is not a proxy statement, earnings release, or other report type. The primary purpose is to announce corporate governance changes related to the IPO. Therefore, the filing type corresponds to a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories but are regulatory in nature.
2018-11-20 English
FORM 4 SUBMISSION
Director's Dealing
2018-11-16 English
FORM 4 SUBMISSION
Director's Dealing
2018-11-16 English
FORM 4 SUBMISSION
Director's Dealing
2018-11-16 English
FORM 4 SUBMISSION
Director's Dealing
2018-11-16 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.